Collate

Raised $95M in a Series A round, announced 7 June 2026.

Latest round Series ACountry United StatesSector AI

Round

Collate raised a $95 million Series A to expand its AI platform for regulated life sciences workflows.

Amount: $95M
Stage: Series A
Announced: 7 June 2026
Lead: Redpoint Ventures
Other investors: First Round Capital, CRV, Conviction, Y Combinator
Use of funds: scale its engineering capacity, accelerate its product development timeline, and expand enterprise sales across international pharmaceutical and medical device corporations.
Total raised: $125M to date
Valuation: $1B
Checked: Amount and date checked against the press source
Source: Collate Raises $95 Million Series A To Expand AI Platform For Regulated Life Sciences Workflows - Pulse 2.0 Pulse 2.0

AI platform for workflows in regulated life sciences companies.

What is Collate's valuation?

Collate was valued at $1B post-money when it raised $95M in its Series A round on 7 June 2026, according to the announcement.

How much has Collate raised?

Collate raised $95M in a Series A round, announced on 7 June 2026.

Who invested in Collate?

Redpoint Ventures led. Investors include Redpoint Ventures, First Round Capital, CRV, Conviction and Y Combinator.